Keynote Speakers
DR KAREN MIGA
Dr. Miga is an Associate Professor in the Biomolecular Engineering Department at UCSC, Director of the UCSC Sequence Technology Centre, and an Associate Director of the UCSC Genomics Institute. In 2019, she co-founded the Telomere-to-Telomere (T2T) Consortium, an open, community-based effort to generate the first complete assembly of a human genome. Additionally, Dr. Miga is the Director of the Genome Center for the Human Pangenome Reference Consortium (HPRC).
DR JOANNE NGEOW
co-sponsored by Cancer SIG
Dr Joanne Ngeow, BMedSci, MBBS, FRCP, MPH, PhD is Senior Consultant, Division of Medical Oncology at the National Cancer Centre Singapore and Associate Professor (Genomic Medicine) at the Lee Kong Chian School of Medicine, Nanyang Technological University Singapore. Dr Ngeow currently heads the Cancer Genetics Service at the National Cancer Centre Singapore with an academic clinical interest in hereditary cancer syndromes and translational clinical cancer genetics.
PROF LOUISE BICKNELL
Sutherland Lecture
Professor Louise Bicknell’s passion is providing families with answers about the cause of genetic conditions affecting their children. Her team uses DNA analysis and molecular biology approaches to discover and understand how previously unexplored genes underlie genetic disorders, with a focus on helping children with neurodevelopmental disorders or growth impairment. She works closely with clinical genetics and diagnostic laboratories in New Zealand, and has a significant international collaborator network, together enabling the identification of more than 25 novel disease genes, providing answers for > 300 families globally. She is Co-Director of Genetics Otago Research Centre, and instigated New Zealand’s involvement in the Horizon Europe funded European Rare Disease Research Alliance (ERDERA), for which she is now the Principal Representative for New Zealand on the ERDERA Governing Board.
PROF STEPHEN ROBERTSON
HGSA Oration
Stephen Robertson is the Curekids Professor of Paediatric Genetics at Otago University in Dunedin, New Zealand. He specialized in Paediatrics, Clinical Genetics and Molecular Genetics after training in Auckland, Melbourne and Oxford. At Otago he directs the Laboratory for Genomic Medicine which focuses on research into the aetiology, diagnosis, pathogenesis and treatment of genetic disorders. He continues to be an actively practicing clinical geneticist with particular interests in the delivery of genomic medicine with a focus on equity, and the development of diagnostic tests for genetic conditions affecting children. He has been awarded of the Health Research Council of New Zealand’s Liley Medal for significant contributions in biomedical health research in 2010 and the Hercus Medal by the Royal Society of New Zealand in 2022.
STEVEN HARRISON
co-sponsored by ASDG SIG
Steven Harrison, PhD, FACMG, is an ABMGG board-certified molecular geneticist working as Genomic Science Director at Ambry Genetics. His work focuses on variant classification approaches and standardization at both a CLIA-certified molecular diagnostic laboratory and as part of the NIH-funded Clinical Genome Resource (ClinGen) program. Within ClinGen, Steven co-chairs the Variant Classification Working Group, which aims to develop general recommendations to the ACMG-AMP variant classification guidelines. He completed his PhD in Genetics & Development in 2014 at the University of Texas Southwestern Medical Center and completed his ABMGG Clinical Molecular Genetics and Genomics fellowship in 2018 at Harvard Medical School.
Invited Speakers
Conference Secretariat
PO Box 7336, Alexandria NSW 2015
P: (61) 2 9669 6600 E: conference@aacb.asn.au